These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21863207)

  • 1. Anxiety, psychosis and substance use: prevalence, correlates and recognition in an outpatient mental health setting.
    Wyman KM; Chamberlain JA; Castle DJ
    Afr J Psychiatry (Johannesbg); 2011 Jul; 14(3):218-24. PubMed ID: 21863207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity Profiles of Psychotic Patients in Emergency Psychiatry.
    Lecomte T; Giguère CÉ; Cloutier B; Potvin S;
    J Dual Diagn; 2020; 16(2):260-270. PubMed ID: 31983294
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality.
    Dilsaver SC; Akiskal HS; Akiskal KK; Benazzi F
    J Affect Disord; 2006 Dec; 96(3):249-58. PubMed ID: 16904187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety Symptoms in Psychotic Disorders: Results from the Second Australian National Mental Health Survey.
    Bosanac P; Mancuso SG; Castle DJ
    Clin Schizophr Relat Psychoses; 2016; 10(2):93-100. PubMed ID: 27440210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-occurring mental illness, substance use disorders, and antisocial personality disorder among clients of forensic mental health services.
    Ogloff JR; Talevski D; Lemphers A; Wood M; Simmons M
    Psychiatr Rehabil J; 2015 Mar; 38(1):16-23. PubMed ID: 25799303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of co-occurring mood and anxiety disorders among substance-abusing youth.
    Lubman DI; Allen NB; Rogers N; Cementon E; Bonomo Y
    J Affect Disord; 2007 Nov; 103(1-3):105-12. PubMed ID: 17291589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients.
    Havassy BE; Arns PG
    Psychiatr Serv; 1998 Jul; 49(7):935-40. PubMed ID: 9661229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between psychotic symptoms and substance use in young offenders.
    Degenhardt L; Coffey C; Hearps S; Kinner SA; Borschmann R; Moran P; Patton G
    Drug Alcohol Rev; 2015 Nov; 34(6):673-82. PubMed ID: 26084677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problem gambling and substance use in patients attending community mental health services.
    Manning V; Dowling NA; Lee S; Rodda S; Garfield JBB; Volberg R; Kulkarni J; Lubman DI
    J Behav Addict; 2017 Dec; 6(4):678-688. PubMed ID: 29254361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis.
    Fusar-Poli P; Nelson B; Valmaggia L; Yung AR; McGuire PK
    Schizophr Bull; 2014 Jan; 40(1):120-31. PubMed ID: 23180756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Simon NM; Otto MW; Wisniewski SR; Fossey M; Sagduyu K; Frank E; Sachs GS; Nierenberg AA; Thase ME; Pollack MH
    Am J Psychiatry; 2004 Dec; 161(12):2222-9. PubMed ID: 15569893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of dual diagnosis among clinic attending patients in a de-addiction centre of a tertiary care hospital.
    Subodh BN; Hazari N; Elwadhi D; Basu D
    Asian J Psychiatr; 2017 Feb; 25():169-174. PubMed ID: 28262143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries.
    Salokangas RK; Ruhrmann S; von Reventlow HG; Heinimaa M; Svirskis T; From T; Luutonen S; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Klosterkötter J;
    Schizophr Res; 2012 Jul; 138(2-3):192-7. PubMed ID: 22464922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of comorbidity 8 years after a first psychotic episode.
    Farrelly S; Harris MG; Henry LP; Purcell R; Prosser A; Schwartz O; Jackson H; McGorry PD
    Acta Psychiatr Scand; 2007 Jul; 116(1):62-70. PubMed ID: 17559602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research.
    Wigman JT; van Nierop M; Vollebergh WA; Lieb R; Beesdo-Baum K; Wittchen HU; van Os J
    Schizophr Bull; 2012 Mar; 38(2):247-57. PubMed ID: 22258882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronology of comorbid and principal syndromes in first-episode psychosis.
    Strakowski SM; Keck PE; McElroy SL; Lonczak HS; West SA
    Compr Psychiatry; 1995; 36(2):106-12. PubMed ID: 7758295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.